E
Xeris Biopharma Holdings, Inc. XERS
$3.18 $0.1053.42%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2023 06/30/2023 03/31/2023 12/31/2022 09/30/2022
Revenue 48.32M 38.01M 33.20M 33.14M 29.73M
Total Other Revenue -- -- -- -- --
Total Revenue 48.32M 38.01M 33.20M 33.14M 29.73M
Cost of Revenue 8.20M 7.56M 5.32M 6.29M 5.26M
Gross Profit 40.12M 30.45M 27.88M 26.85M 24.47M
SG&A Expenses 37.29M 37.64M 33.61M 25.76M 34.49M
Depreciation & Amortization 2.71M 2.71M 2.71M 2.71M 2.71M
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 53.23M 53.99M 46.47M 39.71M 48.51M
Operating Income -4.91M -15.98M -13.28M -6.57M -18.78M
Income Before Tax -12.53M -20.52M -16.83M -13.27M -22.17M
Income Tax Expenses -338.00K -675.00K -- -338.00K -339.00K
Earnings from Continuing Operations -12.19M -19.84M -16.83M -12.93M -21.83M
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -12.19M -19.84M -16.83M -12.93M -21.83M
EBIT -4.91M -15.98M -13.28M -6.57M -18.78M
EBITDA -1.81M -12.88M -10.20M -3.49M -15.71M
EPS Basic -0.09 -0.14 -0.12 -0.10 -0.16
Normalized Basic EPS -0.05 -0.10 -0.08 -0.04 -0.10
EPS Diluted -0.09 -0.14 -0.12 -0.10 -0.16
Normalized Diluted EPS -0.05 -0.10 -0.08 -0.04 -0.10
Average Basic Shares Outstanding 138.06M 137.34M 137.14M 135.99M 135.95M
Average Diluted Shares Outstanding 138.06M 137.34M 137.14M 135.99M 135.95M
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --
Weiss Ratings